| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Inovio Pharmaceuticals, Inc. (INO) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. INO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 41.8K | $46.0K | - | |
| Other | 17.9K | $19.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2019 | Kim Jong Joseph | Chief Executive Officer | Sell | 2,129,553 | $2.36 | $5,017,653.50 | -30.2% | |
| May 21, 2019 | Kim Jong Joseph | Chief Executive Officer | Sell | 100,000 | $3.31 | $331,000.00 | -4.0% | |
| May 16, 2019 | Kim Jong Joseph | Chief Executive Officer | Sell | 136,768 | $3.50 | $478,688.00 | -4.0% | |
| Nov 29, 2018 | Kies Peter73 | CFO | Sale+OE | 10,001 | $5.28 | $52,805.28 | -13.9% | |
| Sep 12, 2018 | Kim Jong Joseph | Chief Executive Officer | Sale+OE | 49,060 | $5.37 | $263,452.20 | -2.1% | |
| Jul 10, 2018 | Kies Peter73 | CFO | Sale+OE | 35,000 | $4.44 | $155,250.00 | -20.7% | |
| Apr 16, 2018 | Weiner David B.82 | Director | Sell | 9,000 | $4.91 | $44,202.60 | -1.2% | |
| Apr 13, 2018 | Kim Jong Joseph | Chief Executive Officer | Sale+OE | 211,250 | $5.10 | $1,076,552.63 | -4.4% | |
| Apr 12, 2018 | Benito Simon X80 | Director | Sale+OE | 3,750 | $5.23 | $19,618.88 | -11.9% | |
| May 25, 2017 | Weiner David B.82 | Director | Sell | 8,000 | $8.00 | $64,016.00 | -1.1% |